Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors With the Clinical Application of FAPI Imaging?. (8th April 2023)

• Record Type: Journal Article
• Authors: Delgado Bolton, Roberto C.; Calapaquí Terán, Adriana K.; Herrmann, Ken; Fanti, Stefano; Giammarile, Francesco
• Is Part Of: Clinical nuclear medicine. Volume 48:Number 4(2023)
• Page Start: 318
• Page End: 319
• Publication Date: 2023-04-08
• Subjects: cancer -- digestive cancer -- FAPI -- FDG -- gastrointestinal tumors -- hepatocellular carcinoma -- imaging -- NEN -- pancreatic cancer -- PDAC -- PET/CT; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000004602
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract: Studies with [ 68 Ga]Ga-labeled or [ 18 F]F-labeled fibroblast activation protein inhibitor compounds have demonstrated favorable characteristics for PET/CT imaging, making them especially interesting for digestive tumors. In this review, the recent evidence in this field and its potential clinical applications are discussed.